0 Commenti
0 condivisioni
369 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Immuno-Oncology and ADCs Market Industry Analysis Report by Product, Application & End UserAccording to the latest report published by Data Bridge Market Research, the Immuno-Oncology and ADCs Market The global immuno-oncology & ADCs market size was valued at USD 11.88 billion in 2024 and is expected to reach USD 34.12 billion by 2032, at a CAGR of 14.10% during the forecast period Immuno-Oncology and ADCs Market report endows with the data and statistics on the current...0 Commenti 0 condivisioni 88 Views 0 Anteprima
-
Long-Acting Injectable Oncology Drug Market Intelligence Report with Demand AnalysisAccording to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period Winning Long-Acting Injectable Oncology Drug Market research...0 Commenti 0 condivisioni 12 Views 0 Anteprima
-
Oncology Blockbuster Drugs Market Trends and Future Growth"What’s Fueling Executive Summary Oncology Blockbuster Drugs Market Size and Share Growth Global oncology blockbuster drugs market size was valued at USD 31.99 billion in 2024 and is projected to reach USD 63.49 billion by 2032, with a CAGR of 8.00% during the forecast period of 2025 to 2032. To stand apart from the competition, a careful idea about the competitive landscape,...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Oral Targeted Oncology Drug Market Report: Growth Analysis, Trends & Future Outlook"Executive Summary Oral Targeted Oncology Drug Market Market: Growth Trends and Share Breakdown The global oral targeted oncology drug market size was valued at USD 20.73 billion in 2025 and is expected to reach USD 43.47 billion by 2033, at a CAGR of 9.70% during the forecast period In this competitive marketplace, businesses are always in struggle to seek...0 Commenti 0 condivisioni 459 Views 0 Anteprima
-
Post-CDK4/6 Treatment Line Oncology Drugs Market Industry Assessment: Demand Trends and Outlook 2025–2033According to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The reliable Post-CDK4/6...0 Commenti 0 condivisioni 16 Views 0 Anteprima
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market research...0 Commenti 0 condivisioni 512 Views 0 Anteprima
-
Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...0 Commenti 0 condivisioni 370 Views 0 Anteprima
-
5-Aminolevulinic Acid Hydrochloride (ALA) Market: Photodynamic Therapy Advancements, Dermatology and Oncology Applications, and Agricultural Biotechnology Trends"In-Depth Study on Executive Summary 5-Aminolevulinic Acid Hydrochloride (ALA) Market Size and Share Data Bridge Market Research analyses that the 5-aminolevulinic acid hydrochloride (ALA) market will witness a CAGR of 3.6% for the forecast period of 2022-2029 and is likely to reach at USD 1020 million by the end of the forecast period of 2022-2029. Trustworthy sources such as websites,...0 Commenti 0 condivisioni 741 Views 0 Anteprima
-
Advancements in NK Cell Engineering and Bispecific Antibodies Driving the Market's Explosive Growth in Oncology.The enormous potential of **Natural Killer (NK) cell therapeutics** stems not just from the cells themselves but from technological breakthroughs in their engineering and strategic combination with other agents, most notably **bispecific antibodies**. The inherent limitations of unmodified NK cells—specifically their short lifespan, poor persistence *in vivo*, and difficulty penetrating...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Antibody Drug Conjugates (ADCs) Market to Witness Accelerated Growth Amid Rising Oncology InnovationsThe Antibody Drug Conjugates (ADCs) Market has moved from niche oncology innovation to one of the most closely watched segments in biopharmaceutical development. Once considered technically complex and commercially uncertain, ADCs now represent a validated therapeutic platform with multiple regulatory approvals and an expanding clinical pipeline. In simple terms, ADCs combine the...0 Commenti 0 condivisioni 514 Views 0 Anteprima
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Commenti 0 condivisioni 769 Views 0 Anteprima
-
Anastrozole Tablets Market: Trends, Growth Drivers, and Competitive Analysis"In-Depth Study on Executive Summary Anastrozole Tablets Market Size and Share The global anastrozole tablets market size was valued at USD 410.71 million in 2025 and is expected to reach USD 512.25 million by 2033, at a CAGR of 2.80% during the forecast period The Anastrozole Tablets Market report has been designed by keeping in mind the customer...0 Commenti 0 condivisioni 565 Views 0 Anteprima
-
Are Personalized Oncology Approaches Accelerating the Tumor Markers Testing Market?Key Drivers Impacting Executive Summary Tumor Markers Testing Market Size and Share CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The Tumor Markers Testing Market report contains market insights and analysis for Tumor...0 Commenti 0 condivisioni 586 Views 0 Anteprima
-
Biosimilar Bevacizumab Market Poised for Robust Growth as Cost-Effective Oncology Therapies Gain TractionThe global Biosimilar Bevacizumab Market is on a robust growth trajectory, driven by the increasing demand for affordable cancer treatments, the expiration of patents on the reference biologic Avastin, and supportive regulatory frameworks. According to a comprehensive report by Market Research Future, the market was valued at USD 1.814 billion in 2024. It is projected to grow from USD...0 Commenti 0 condivisioni 479 Views 0 Anteprima
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commenti 0 condivisioni 516 Views 0 Anteprima
Pagine in Evidenza
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek